0:00
/
0:00

Paid episode

The full episode is only available to paid subscribers of The Biotech Capital Compass

Biotech Buzz: Pain, Policy, and Potential

From FDA exits to tariff drama, we explore how investors are navigating a sector on edge.

Biotech Market Update: March 21 – April 13, 2025

In this episode, we recap a volatile stretch for biotech and the broader markets, starting with a nod to Rory McIlroy’s Masters win and springtime reflection in Lake Tahoe. The script dives into FDA shakeups, key upcoming PDUFA dates (including Abeona, Verastem, and Outlook Therapeutics), and a biotech sec…

Listen to this episode with a 7-day free trial

Subscribe to The Biotech Capital Compass to listen to this post and get 7 days of free access to the full post archives.